Abstract
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.
| Original language | English |
|---|---|
| Article number | 25 |
| Journal | EJNMMI Radiopharmacy and Chemistry |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Oct 2022 |
Bibliographical note
FundingOpen Access funding enabled and organized by Projekt DEAL.
Publisher Copyright: © 2022, The Author(s).
Fingerprint
Dive into the research topics of 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver